- TheStreet.com•2 days ago
AstraZeneca shares, meanwhile, were less-than-moved by the news.
- TheStreet.com•2 months ago
The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.
- Motley Fool•2 months ago
I should have bought shares of this biotech winner when I had the chance.
Requested symbol wasn't found
|Bid||N/A x N/A|
|Ask||N/A x N/A|
|Day's Range||N/A - N/A|
|52 Week Range||undefined - undefined|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||N/A|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|